The French market for spinal fusion is a globally competitive market subject to rapid technological change, new product introductions and, other market activities of industry participants. The French market has been quite difficult for most foreign companies due to its low prices and the number of French competitors. We should not forget that French surgeons and companies played a decisive role in the early days of the spine market. The French company Sofamor, acquired by Medtronic at the end of the 1990s, led the worldwide spine market from the beginning until today.
Spine Market
The French market can be valued at 11.5 billion in 2022 with a CAGR of 5% during the 2020-2025 period. The major growth factor is the increasing number of degenerative procedures due to the aging and obese population.
Competition
The most significant competitors are Medtronic (recently they acquired Medicrea), DePuy Synthes (Johnson&Johnson), Stryker, Zimmer Biomet (they bought LDR in the past to increase their position), and many french companies like the following:
To know more about each of them, please visit: https://thespinemarketgroup.com/category/companies/france/
- Biotechni
- Clariance
- Cousin Biotech
- EUROS International
- Eurospine
- FRADIS Medical
- H.P.I. Medical
- Hyperprevention
- Implanet
- InTech Medical
- LISI MEDICAL
- MEDICREA (acquired by Medtronic)
- Neuro France Implants
- NovaSpine
- OSD
- Safe Orthopaedics
- SMAIO
- Spine Innovations
- SpineGuard
- SpineVision
- Spineway
- Teknimed
- Yellowsteps